Upcoming Medical Conferences in Bethesda

9th Annual Red Cell Genotyping Symposium is organized by Versiti and will be held on Sep 20, 2019 at National Institutes of Health, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

2019 Adult Congenital Heart Disease (ACHD) Conference is organized by MedStar Health and will be held from Oct 04 - 05, 2019 at Bethesda Marriott, Bethesda, Maryland, United States of America.  Target Audience Anesthesiology, Cardiac Electrophysiology, Cardiac Surgery, Cardiovascular Disease, Obstetrics, Pediatrics. Credits:  AMA PRA Category 1™ Physician (12.50), Nurse - ANCC (12.50), Non-Physician Member of the Healthcare Team (12.50), IPCE (12.50) Course Description: Due to advances in medical and surgical therapies for patients with congenital heart disease (CHD), children and adolescents with CHD have over a 90% survival rate. As a result, the number of adults with CHD in the United States has now surpassed the number of children with these conditions. This two-day program offers physicians and other health care providers a comprehensive review of the evaluation, diagnosis and management of adult congenital heart disease, including the management of heart disease during pregnancy. Through a series of multidisciplinary lectures and question and answer sessions the ACHD conference invites all disciplines to examine the progression and treatment of congenital heart disease from adolescence through adulthood. Track 1 will be an interactive multidisciplinary session integrating expertise from cardiologists, anesthesiologists, and maternal fetal medicine specialists on the care of the pregnant patient with cardiac disease. Women with CHD are 8 times as likely to experience cardiovascular complications during pregnancy and have a 6 times higher risk of dying than women without CHD. Managing these patients through pregnancy safely can be challenging and requires a multidisciplinary approach. This track will be case based, with an opportunity for discussion and interaction with the experts. Track 2 will be an interactive session that focuses on specific cardiac defects by providing an integrated anatomy review with 3D heart models, imaging review with a focus on echocardiogram and MRI, and key clinical management review. The session will include audience response questions and an opportunity to review 3D heart models with experts in cardiac pathology.  Course Objectives: At the conclusion of this activity, the learner will be able to: • Identify the increasing prevalence of adults with congenital heart disease and address some of the complications that can result from lifelong congenital heart disease. • Consult and coordinate with expert maternal-fetal medicine care for optimization of outcomes for mothers and babies. • Review current and innovative imaging techniques for simple and complex congenital heart lesion. • Review new and innovative PAH therapies that might be utilized for patients with adult congenital heart disease • Review new and innovative advanced mechanical support therapies that might be utilized for patients with adult congenital heart disease • Consult and coordinate with ACHD and PH experts for the care of ACHD patients with PAH and single ventricle heart disease • Consult and coordinate with ACHD experts for cardiac transplantation and advanced mechanical support evaluation in ACHD patients • Recognize the importance of consulting ACHD specialists in the evaluation and care of pregnant ACHD patients • Appraise the catheter-based interventional procedures in adults with congenital heart disease. • Appraise the indications of pacemaker and defibrillator therapy in adults with congenital heart disease. • Identify the increasing prevalence of adults with congenital heart disease and address some of the complications that can result from lifelong congenital heart disease. • Consult and coordinate with expert maternal/fetal medicine care for optimization of outcomes for mothers and babies and determining appropriate contraceptive options. • Identify underlying cardiac anatomy and structural repairs in congenital heart disease Additional details will be posted as soon as they are available. 

Sensory Nutrition and Disease Workshop is organized by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and will be held from Nov 12 - 13, 2019 at Natcher Conference Center, Bethesda, Maryland, United States of America. Background: Many of our most serious and intractable health problems—including obesity, type 2 diabetes, hypertension, heart disease, and cancer-are linked to what we choose to eat and drink. What we choose to eat and drink is driven largely by the sensory properties of food: taste, smell, and texture. As molecular tools in model organisms become increasingly sophisticated, how can this new information be translated to testable hypotheses to the betterment of human health? Objectives: • Understand both the hedonic pathways linked to tasting and sensing of food. • Understand the physiological roles of chemosensory receptors and how these taste and smell sensors are involved in nutrition. Additional details will be posted as soon as information is available.

22nd International 3S Symposium is organized by STAR Institute for Sensory Processing Disorder (SPD) and will be held from Nov 15 - 16, 2019 at Hyatt Regency Bethesda, Bethesda, Maryland, United States of America. Who should attend: Occupational therapists, speech language pathologists, physical therapists, special education teachers, psychologists, early intervention specialists, nurses, physicians, mental health professionals, parents and other individuals seeking a better understanding of Sensory Processing Disorder. Continuing Education: 2-day Symposium: 11 Hours (1.1 AOTA CEU) 1-day: Symposium: 5.5 Hours (.55 AOTA CEU) Friday, November 15 OR Saturday, November 16 Attend in person or participate via live-stream from anywhere with internet access!* Join us for the 22nd International 3S Symposium as we discuss ​the primary role sensory processing and sensory motor integration ​play in everything that we do and what that means for participation, function and self-actualization. ​Speakers from across a variety of disciplines will delve into the interplay of sensory processing and sensory motor experience with mental health domains and meaningful participation. This knowledge will transform your clinical practice by reframing challenging behaviors, supporting improved function and maximizing experiences of success for your clients and their families.  Explore the crucial role sensory processing/sensory motor experience plays in shaping human development. We will examine the impact of sensation on ‘sense of self’ and self-agency. An expanded focus will include how the ‘self’ interacts within the external environment. Discover how both positively affect the individual’s relationships within the family and the community, as well as positively grow the individual’s physical capacities to interact in the world. This conference is designed for clinicians, researchers and professionals working with neurodiverse populations, including: occupational therapists, physical therapists, speech language pathologists, educators, child development specialists and mental health professionals. We also welcome parents, caregivers and carers, as well as individuals with disordered sensory processing. Professionals may also choose to attend the Pre-Symposium Professional Workshop* or Pre-Symposium Parent Workshop taking place the day before the Symposium. *The November 14, 2019 Pre-Symposium Professional Workshop will not be livestreamed.

Building Interdisciplinary Research Careers in Women's Health (BIRCWH) - Annual Meeting is organized by NIH Office of Research on Women's Health (ORWH) and will be held on Dec 11, 2019 at Natcher Conference Center, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

Strategies for Clinical Imaging in Diabetes is organized by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and will be held from Jan 13 - 15, 2020 at National Institutes of Health campus, Bethesda, Maryland, United States of America. Description: The ability to noninvasively image the cell types of the pancreatic islet and their function, particularly the beta cell, would allow diabetes researchers to observe and learn about the natural history of diabetes in living human beings. Most of the information we have currently about the fate of the insulin-producing cells comes from single snapshots taken in cadaver pancreas from people in various stages of diabetes. At this time, there are several promising imaging agents in various stages of development and validation. Objectives: This workshop is designed to provide a forum for discussion of the state of the art of in vivo imaging of the pancreatic islet beta cell mass and function, and the next steps toward this important goal. Additional details will be posted as soon as information is available.

Imaging the Pancreas in Diabetes, and Benign and Malignant Exocrine Pancreatic Disease is organized by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and will be held from Jan 13 - 15, 2020 at NIH Campus, Bethesda, Maryland, United States of America. Background: There are a large number of questions that are arising from clinical experience in the exocrine pancreas field that impact issues of diabetes pathogenesis, and vice versa—the observation of substantial changes in exocrine size and likely architecture that precede diabetes onset is one striking example of this. Other examples include inflammation and changes in organ blood flow, and the incidence of diabetes (both T1D and T2D) with exocrine diseases of various sorts. Treatment of a disease with an endocrine or exocrine pathogenesis can affect the function (good and bad) of the entire pancreas. It has become clear that while the endocrine and exocrine pancreas are studied by different communities, and the diseases are treated by people in different medical disciplines, there is a great deal to be learned at the intersection. Imaging of the pancreas is at that intersection. Many of the goals for imaging in the pancreas are similar for endocrinologists and pancreatologists, and include size, architecture and tissue physical properties such as stiffness, vasculature, nerves, inflammation, fibrosis and fat deposition. Even imaging goals specific to different disciplines, such as the goals to image islet and beta cell mass and function or to visualize tumors, can yield information that is likely to inform both communities of scientists and clinicians. Objectives: The goal of this symposium is to showcase the use of imaging in the pancreas to detect and explore the pathogenesis of diabetes, pancreatic cancers, pancreatitis and other pancreatic diseases, in humans and model systems. The emphasis is on observations and biology from the fields of diabetes and pancreas disease research that can potentially inform each other. Additional details will be posted as soon as information is available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on Jan 31, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.

2020 American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting is organized by American Society for Experimental Neurotherapeutics (ASENT) and will be held from Mar 02 - 05, 2020 at Hyatt Regency Bethesda, Bethesda, Maryland, United States of America. Description: The ASENT 2020 Annual Meeting features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of DBS, spinal cord stimulation, genomic-based drug discovery, new drug delivery systems. Additional details will be posted as soon as they are available.

National Deafness and Other Communication Disorders Advisory Council (NDCD) Meeting is organized by National Institute on Deafness and Other Communication Disorders (NIDCD) and will be held on May 29, 2020 at National Institute on Deafness and Other Communication Disorders, Bethesda, Maryland, United States of America. Additional details will be posted as soon as they are available.